RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's level of EUR 833.5 million. EBITDA improved to EUR 57.0 million from EUR 46.7 million in the prior year, and consolidated profit rose to EUR 22.5 million compared to EUR 14.7 million in H1 2025. The results were significantly impacted by immediate transformation costs established to offset higher personnel and material costs from previous years.
Patient numbers increased by 9% to 513,700 treated on an outpatient and inpatient basis across the Group's hospitals and medical care centers, up from 471,295 in the first half of 2025. The company continues to invest in expanding regional health networks, with a focus on improving healthcare provision. In Hesse, Universitatsklinikum Marburg and the pulmonary clinic Lungenfachklinik Immenhausen have formed a strategic partnership to enhance care for lung patients. In Brandenburg, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site, along with cooperation agreements with the City of Frankfurt (Oder) and the District of Oder-Spree, aims to ensure coordinated help for affected children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently.” He added that collaboration across providers is essential to ensure comprehensive and high-quality care, especially in rural areas.
Dr. Stefan Stranz, also on the Board of Management, expressed concerns about recent legislation: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
For the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates a moderate improvement in non-financial performance indicators, such as number of cases and cost weights, compared to the previous year.
However, the financial year will be significantly affected by ongoing legislative changes, including the Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act (GKV-BStabG), which aim to improve quality and efficiency but will increase financial pressure on hospitals in the short term. The company notes that the forecast is subject to considerable uncertainties due to regulatory interference, implementation of hospital reform, and potential further adjustments by the legislator. Global crises and negative economic impacts, including higher prices and supply bottlenecks, also contribute to market volatility.
The interim report for the first half of 2026 is published on the company's website at www.rhoen-klinikum-ag.com.
